Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
59.69 USD | -0.98% | -0.86% | -24.34% |
01:42pm | CVS Store-Brand Medications Face Quality Concerns and Higher Recall Rates | MT |
Jun. 08 | Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE |
Financials (USD)
Sales 2024 * | 370B | Sales 2025 * | 387B | Capitalization | 75.67B |
---|---|---|---|---|---|
Net income 2024 * | 7.38B | Net income 2025 * | 8.69B | EV / Sales 2024 * | 0.34 x |
Net Debt 2024 * | 49.19B | Net Debt 2025 * | 45.81B | EV / Sales 2025 * | 0.31 x |
P/E ratio 2024 * |
10.6
x | P/E ratio 2025 * |
8.98
x | Employees | 259,500 |
Yield 2024 * |
4.41% | Yield 2025 * |
4.57% | Free-Float | 70.66% |
Latest transcript on CVS Health Corporation
1 day | -0.89% | ||
1 week | -0.85% | ||
Current month | +0.24% | ||
1 month | +5.80% | ||
3 months | -21.33% | ||
6 months | -19.00% | ||
Current year | -24.34% |
Managers | Title | Age | Since |
---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 18-11-27 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 22-01-31 |
Tilak Mandadi
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 11-01-19 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 18-11-27 |
Mary Schapiro
BRD | Director/Board Member | 68 | 17-05-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.92% | 21 M€ | +8.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 59.74 | -0.89% | 3 064 984 |
24-06-10 | 60.28 | -2.43% | 10,633,370 |
24-06-07 | 61.78 | +1.38% | 12,239,983 |
24-06-06 | 60.94 | +0.40% | 9,545,860 |
24-06-05 | 60.7 | +0.73% | 8,933,039 |
Delayed Quote Nyse, June 11, 2024 at 10:53 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.34% | 75.67B | |
+25.01% | 89.38B | |
+6.34% | 28.83B | |
+5.17% | 18.25B | |
-13.62% | 16.51B | |
+1.88% | 15.72B | |
+76.07% | 13.71B | |
+81.13% | 13.46B | |
+23.28% | 12.64B | |
+33.79% | 12.42B |
- Stock Market
- Equities
- CVS Stock